author-photo

Elizabeth McNeil

33

Papers

25

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

Variables Affecting Outcomes After Allogeneic Hematopoietic Stem Cell Transplant for Cerebral Adrenoleukodystrophy.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Elivaldogene Autotemcel (eli-cel, Lenti-D) Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy: Updated Results from the Phase 2/3 ALD-102 Study and First Report on Safety Outcomes from the Phase 3 ALD-104 Study

2021
Show All
- Source
- Cite
- Save
Citations (1)
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Cerebral Adrenoleukodystrophy: Effects of Donor Cell Source and Match, Conditioning Regimen, and Stage of Cerebral Disease

2021
Show All
- Source
- Cite
- Save
Citations (0)
Disease Stabilization Following Treatment with elivaldogene autotemcel (eli-cel, Lenti-D) Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy: Interim Results from Phase 2/3 (ALD-102) and Phase 3 (ALD-104) Studies (2064)

2021 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Safety of Autologous Hematopoietic Stem Cell Transplantation with Gene Addition Therapy for Transfusion-Dependent β-Thalassemia, Sickle Cell Disease, and Cerebral Adrenoleukodystrophy

2020 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (2)
Transplant- and Disease-Related Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Cerebral Adrenoleukodystrophy Vary By Donor Cell Source, Conditioning Regimen, and Stage of Cerebral Disease

2020 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Updated Safety and Efficacy Outcomes from an Ongoing Phase 2/3 Trial of Lenti-D Autologous Hematopoietic Stem Cell Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy

2019 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (1)
Mapping Queer Space

2017
Show All
- Source
- Cite
- Save
Citations (0)
NN 102/SPRINT-MS Phase II Trial of Ibudilast in Progressive MS: Baseline Characteristics (P7.214)

2015 Neurology
Show All
- Source
- Cite
- Save
Citations (1)
Public Review: The National Institute of Neurological Disorders and Stroke (NINDS) Congenital Muscular Dystrophy (CMD), Facioscapulohumeral Muscular Dystrophy (FSHD) and Myotonic Dystrophy (DM) Common Data Elements (CDE) Recommendations (S25.004)

2015 Neurology
Show All
- Source
- Cite
- Save
Citations (0)